• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number RSINT25026X
Device Problems Device Dislodged or Dislocated (2923); Positioning Problem (3009)
Patient Problems Device Embedded In Tissue or Plaque (3165); Insufficient Information (4580)
Event Date 03/19/2024
Event Type  Injury  
Event Description
An attempt was made to use one resolute integrity drug eluting stent to treat a lesion in the distal right coronary artery (rca).The lesion was pre-dilated.It was reported that the stent could not be delivered to the distal target lesion.When the stent system was withdrawn, stent dislodgement occurred.An attempt to capture the stent failed.The dislodged stent flowed with the blood to the distal segment of the left popliteal artery.The right femoral artery was punctured.  a 6f jr4 guide catheter was inserted into the proximal segment of the left popliteal artery.A 4.0 x 33mm non-medtronic drug eluting stent and a 4.0 x 22mm medtronic drug eluting stent were positioned and deployed at the proximal and distal sections of the dislodged stent in the left popliteal artery which completely covered the dislodged stent.The patient had no discomfort after the surgery.No further patient injury was reported.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19190316
MDR Text Key341119532
Report Number9612164-2024-02001
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberRSINT25026X
Device Catalogue NumberRSINT25026X
Device Lot Number0012009236
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/11/2024
Initial Date FDA Received04/26/2024
Date Device Manufactured10/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient SexMale
-
-